A) zero mentions of providers being concerned with impacts to them from less frequent visits - although 1 provider noted patients are showing up with much less movement and she ascribes it to them having regularly scheduled visits based upon old wearoff rates.
B) why would multiple providers note movement returns at roughly same time as w older BONTs but return to baseline is extended? My guess at some big factors is: 1) non optimum injection pattern for a drug that diffuses less than traditional BONT, so areas outside of pattern wear off too soon, but full fade doesn’t happen until much later, 2) some amount of lesser fidelity for shorter periods. 15% of 8 weeks is a week, of 18 weeks is 2.5 weeks.
Market Data 
Markets 
AI
